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Experimental Procedures
Materials and methods. The chemical reagents were purchased from Aldrich or TCI. Monoamine oxidase A and B (2.5 mg/vial) were purchased from Sigma Aldrich. Pargyline was purchased from Sigma. Commercially available reagents were used without further purification. Anhydrous solvents for organic synthesis were prepared by passing through a solvent purification tower. Thin-layer chromatography (TLC) was performed on precoated silica gel 60F-254 glass plates. 1 H and 13 C NMR spectra were measured with a Bruker DPX-300 and DPX-500. Coupling constants (J value) are reported in Hertz. Mass spectral analysis was recorded with Jeol JMS 700 and was reported in units of mass to charge (m/z). HRMS was performed at the Korea Basic Science Center, Kyungpook National University.
N-tert-Butyloxycarbonyl-3-(chloropropyl)carbamic acid tert-butyl ester (7a). To a solution of 3-chloropropylamine hydrochloride (1.30 g, 10 mmol) in dichloromethane (4.5 mL) was added triethylamine (1.67 mL, 12 mmol) dropwise, and the resulting solution was stirred for 15 min. Next, a solution of di(tertbutyl)dicarbonate (2.18 g, 10 mmol) in dichloromethane (4.5 mL) was added dropwise to the amine solution over a period of 1 h, and the resulting mixture was stirred overnight at room temp. The reaction mixture was diluted with dichloromethane (10 mL), and it was washed sequentially with 1 N HCl (10 mL), water (2 × 5 mL), saturated aqueous NaHCO 3 (1 × 10 mL), and brine (1 × 10 mL). The organic layer was separated, dried over Na 2 SO 4 , and concentrated by rotary evaporation to give compound 12 as a colorless oil (1.5 g, 82% yield), which was used for the next step without further purification: 1 with 4-(dimethylamino)pyridine (559 mg, 4.56 mmol) at room temp, and the resulting mixture was stirred for 10 min. Di-tert-butyl-dicarbonate (1M in THF, 15.0 mL, 15.25 mmol) was added to the reaction mixture, and the resulting mixture was stirred over night at room temp. The reaction was quenched by the addition of water, and the aqueous phase was extracted with EtOAc (3 × 40 mL). The combined organic extracts were washed with 1 M aqueous HCl (50 mL) and brine (4 × 50 mL), and concentrated in vacuo. The residue was purified by silica gel column chromatography (eluent: 10% EtOAc in hexane) to afford compound 7a as a colorless liquid (538 mg, 60% 6-Dimethylamino-3-{3-[N,N-bis(tert-butyloxycarbonyl)amino]propyloxy}naphthalene-2-carbaldehyde (5a). Under a nitrogen atmosphere, 6-dimethylamino-3-hydroxy-naphthalene-2-carbaldehyde 1 (4, 176.7 mg, 0.82 mmol), compound 7a (242 mg, 0.82 mmol), and potassium carbonate (227 mg, 1.64 mmol) were combined in anhydrous DMF (5 mL). The resulting mixture was heated at 50°C for 27 h, and then it was cooled to room temperature, and diluted with EtOAc (100 mL). The mixture was washed with water (3 × 100 mL) and brine (1 × 100 mL), and the organic layer was separated, dried over Na 2 SO 4 , and concentrated. The residue was purified by silica gel column chromatography (eluent: 20% EtOAc in hexane) to afford compound 5a as a yellow solid (271 mg, 71% 
6-Dimethylamino-3-{3-[N-methyl-N-(tert-butyloxycarbonyl)-amino]propyloxy}naphthalene-2-carbaldehyde (5b).
Compound 5b, prepared similarly as 5a using compound 4 and compound 7b, was obtained as a yellow solid (70% 
2-{3-[N,N-bis(tert-butyloxycarbonyl)amino]propyloxy}-3-(2,2-dicyano)vinyl-7-(dimethylamino)naphthalene (6a).
To a stirred solution of compound 5a (152 mg, 0.32 mmol) and malononitrile (43 mg, 0.64 mmol) in ethanol (3 mL) at room temp under argon was added piperidine (316 μL, 3.2 mmol). The reaction mixture was allowed to stir at room temp for 3 h. The solvent was evaporated under reduced pressure, and the resulting residue was purified by silica gel column chromatography (eluent: 30% EtOAc in hexane) to afford compound 6a as a red solid (151 mg, 90% 
2-{[3-(3-Aminopropoxy)-6-(dimethylamino)naphthalen-2-yl]methylene}malononitrile (1a).
Compound 6a (51.1 mg, 0.1 mmol) was added to a solution of trifluoroacetic acid (3 mL) and triisopropylsilane (3 μL) in dichloromethane (3 mL), and the resulting mixture was stirred at 0 °C for 1 h. The reaction was followed by TLC. The solvent was concentrated under reduced pressure to give 1a as a dark red solid, which was pure enough for sensing purpose. 
Moclobemide [4-chloro-(2-morpholinoethyl)benzamide].
To a solution of 4-chlorobenzoyl chloride (0.977 mL, 7.62 mmol) in THF (35 mL) were added 4-(2-aminoethyl)morpholine (1.0 mL, 7.62 mmol) and triethylamine (1.06 mL, 7.62 mmol) at 0 °C over 1 h. During addition, the temperature of the reaction mixture was kept below 5 °C. The resulting mixture was stirred at room temp for 12 h, and then was treated with EtOAc (100 mL) and water (200 mL). The organic layer was separated and evaporated under reduced pressure; the resulting white solid was recrystallized from EtOAc and hexane to give pure Moclobemide (1.95 g, 95% 
Spectroscopic analysis
One-and two-photon spectroscopic analysis of IminoPOS. UV/Vis absorption spectra were obtained using a HP 8453 UV/Vis spectrophotometer. Fluorescence spectra were recorded on a Photon Technical International Fluorescence System (PTI, Photon Technology International) with a 1-cm standard quartz cell. The concentration of IminoPOS and acedan, coumarin 153 dyes were 10 μM. The fluorescence quantum yield was determined by using rhodamine 6G and coumarin 153 as the references. The measurement of two photon emission spectra was performed by using home-built cavity-dumped Ti:sapphire oscillator pumped by a 5.0 W output of a frequency-doubled Nd:YVO4 laser (Verdi, Coherent), which allows us to use excitation wavelengths at 780, 800, and 820 nm. The energy of the output pulses was 40 nJ at the repetition rate of 380 kHz. A 15-cm focal length singlet lens was used to focus the excitation beam to the sample in a 1-mm quartz cell, and the fluorescence was collected in a backscattering geometry using a parabolic mirror. Two-photon cross section (GM) was checked by TPACS (Two-photon induced fluorescence) method and 1 units (GM) value is 10 -50 cm 4 s photon -1 molecule -1 .
2,3 Table S1 . Absorption and emission properties of acedan, coumarin 153, and imino-POS.
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[a] All data were obtained for a 10 μM solution of the fluorophore dissolved in each solvents.
[b] Fluorescence quantum yields were determined using rhodamine 6G (Φ F = 0.6) as a standard. 2 [c] σ (GM) values were determined using rhodamine 6G (GM = 700) as a standard. Fluorescence response of probes 1a and 1b toward MAO A and MAO B. Typically, the enzyme's concentration is fixed at 50 μg/mL. The probe's concentration is fixed at the K m value (1a/MAO A; 70 μM, 1b/MAO A; 252 μM, 1a/MAO B; 75 μM, 1b/MAO B; 210 μM). The fluorescence responses and timedependent fluorescence enhancements were monitored by fluorescence spectrometer with excitation wavelength 448 nm. Time-dependent fluorescence enhancements were monitored at 10 min-intervals at the same conditions ( Figure S6 ). Enzyme kinetic assays. A 96-well fluorescence assay plate was used for this assay. Changes in the fluorescence intensity for each of the reaction mixtures between probes 1 and MAOs (the final enzyme concentration: 10 μg/mL) were monitored after incubating at 37 °C for 3 h, using a microplate spectrofluorometer (VICTOR 3 V TM multilabel counter, Perkin Elmer-Wellesley, MA, USA). Each of the enzyme reactions was performed at 37 °C in a buffer (100 mM HEPES, pH 7.4 with 5% glycerol and 1% DMSO). The fluorescence enhancement was recorded after the 3 h-incubation for each mixture, using a fluorescence VICTOR multilabel counter (the excitation wavelength: 465 nm; the detection wavelength: 600 nm). [a] Probe 1a and 1b: 0-400 μM; MAOs A and B: 10 μg mL −1 ; after incubation for 3 h at 37 °C.
Influence of MAO inhibitors on the enzyme assay with probes 1a. A 96-well fluorescence assay plate was used for this assay. MAO A or B was incubated in the presence of Moclobemide (70 μM) or Pargyline (70 μM) for 2 h at 37 °C, and then it was treated with probe 1a (70 μM) and further incubated for 3 h at 37 °C (the final concentration of the enzyme was 10 μg/mL), during which period the time-dependent fluorescence enhancements were measured at 10-min intervals, using a microplate spectrofluorometer (VICTOR 3 V TM multilabel counter, Perkin Elmer-Wellesley, MA, USA) (the excitation wavelength: 465 nm; the detection wavelength: 600 nm). Two-photon fluorescence microscopy. A point scanning two-photon microscopy (TPM) was used to obtain probe-labeled images. System was build using an upright microscope (BX51; Olympus) with a 20× objective lens (XLUMPLFLN-W 20×, NA 1.0 water immersion, Olympus) and the images were obtained by exciting the probes with a mode-locked femtosecond Ti:Sapphire laser (Chameleon Ultra II, Coherent). The laser source could emit near infrared (NIR) wavelength between 680 nm to 1020 nm with a repetition rate of 80 Mhz and a pulse width of 140 fs. In order to scan the specimen, we used two galvanometer mirror (6215H, Cambridge Technoloogy) allowed x-axis and y-axis scanning. We set the wavelength at 790 nm and 900 nm, which corresponded to approximately 17 mW and 10 mW average power in the focal plane, respectively. In the microscope, the excitation light went through a 680 nm short pass dichroic mirror (DM1, 680DCSPXR, Chroma) and another 680 nm long pass dichroic mirror (DM2, 680DCXXR, Chroma). The emitted fluorescence was passed through the objective and reflected to the detection path by the 680 nm long pass dichroic mirror. It was collected by photomultiplier tube (PMT, H5783P, Hamamatsu) and the signals were constructed an 8 bit unsigned 256 × 256 pixels at 50 ps pixel residence rate (20 Khz). Based on this experiment conditions, fluorescence emission spectra was observed by 900 nm excitation by TPM at 10 mW laser power and 0.382 frame/s imaging speed.
Cell viability assessments. Cell viability was assessed by measuring their ability to metabolize 3-(4,5-dimethyldiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 5 in C6 glioma cell line. Cells were seeded onto 96-well plates at a density of about 5 × 10 3 cells per well in the growth medium and incubated until about 70-80% confluency. Following the treatments as indicated, 25 μL of MTT solution (5 mg/mL) was added to each well, and cells were maintained for 2 h at 37 °C. 100 μl of a solubilizing solution (50% dimethylformamide and 20% SDS, pH 7.4) was then added. After an overnight incubation at 37 °C, absorbance at 570 nm was measured. 
